article thumbnail

Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers

Veriheal

Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. The team peered into the findings of numerous articles published between 2001 and 2019. Chronic pain —a condition that affects 50.2 million people in the U.S.

article thumbnail

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

Veriheal

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study Indicates Cannabis May Alleviate Neuropathic Pain Caused By Chemotherapy

SpeedWeed

Oxaliplatin, the researchers said, “is a platinum-based chemotherapy widely used for the treatment of gastrointestinal (GI) malignancies.” This reduction was more significant in patients who received cannabis prior to treatment with oxaliplatin, suggesting a protective effect. A large prospective trial is planned.”.

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Daily cannabis consumption was an effective treatment for 85% of participants. headaches per month.

Terpenes 132
article thumbnail

Psych Newsletter UK Interviews MP, Crispin Blunt

Cannabis Law Report

The constitutional convention saw the campaign to reschedule psilocybin elevated to national headlines, and a week later British psychedelic company COMPASS Pathways released data from its pivotal Phase IIb trial with psilocybin, which demonstrated its efficacy in treatment-resistant depression.

Policy 52
article thumbnail

India: Bar & Bench Article: Is it time to decriminalise Cannabis use in India?

Cannabis Law Report

The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. The Court insisted that without being experts in the field, it could not examine the technical data regarding useful effects of Ganja etc. Appeals to Parliament.

article thumbnail

Mixing weed and alcohol: the good, the bad and the ugly

The Cannigma

These findings mirror those of a 2001 trial, in which the subjects who consumed alcohol along with cannabis “reported more episodes of euphoria and had higher plasma THC levels.” Arguably, one doesn’t need to see any scientific data to know that the mixing of cannabis and alcohol is more common with younger cannabis users.